Skip to content
2000
Volume 2, Issue 4
  • ISSN: 1566-5232
  • E-ISSN: 1875-5631

Abstract

Herpes Simplex Virus (HSV) has a number of advantages as a gene delivery vector, particularly for the nervous system. Thus, it naturally establishes asymptomatic latent infections of neuronal cells. Moreover, it is readily grown in culture to high titre and has a large genome so allowing it to be used to deliver multiple or very large genes. Considerable progress has been made in effectively disabling the virus so that it does not damage the cells it infects but can still deliver an inserted gene effectively. In addition, it is now possible to obtain long-term expression of the transgene in the nervous system, using regulatory elements derived from the latency-associated transcript of the virus.As well as its use in the nervous system, the virus has also been used to successfully deliver genes to a variety of other cell types, including peripheral blood mononuclear cells and cardiac myocytes within the intact heart. In particular, its ability to deliver genes effectively to replicating cancer cells and to dendritic cells offers considerable potential for the use of this virus in cancer therapy.

Loading

Article metrics loading...

/content/journals/cgt/10.2174/1566523023347698
2002-12-01
2025-05-22
Loading full text...

Full text loading...

/content/journals/cgt/10.2174/1566523023347698
Loading

  • Article Type:
    Review Article
Keyword(s): gene delivery; gene delivery vector; herpes simplex virus; hsv; virus vector
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test